Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Bacterial Infections and Mycoses

Free Subscription Articles published in Nat Med Retrieve available abstracts of 20 articles: HTML format

Single Articles

October 2025
1. PEREZ-SAEZ J, Zheng Q, Kaminsky J, Zou K, et al
   Geographical shifting of cholera burden in Africa and its implications for disease control.
   Nat Med. 2025;31:3380-3387.
   PubMed     Abstract available
   
   
   September 2025
2. KEELEY AJ, Camara FE, Armitage EP, de Crombrugghe G, et al
   Publisher Correction: Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden setting.
   Nat Med. 2025 Sep 24. doi: 10.1038/s41591-025-04017.
   PubMed    
   
   
   
3. PARK JY, Georges D, Alberts CJ, Bray F, et al
   Global lifetime estimates of expected and preventable gastric cancers across 185 countries.
   Nat Med. 2025;31:3020-3027.
   PubMed     Abstract available
   
   
   August 2025
4. KEELEY AJ, Camara FE, Armitage EP, de Crombrugghe G, et al
   Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden setting.
   Nat Med. 2025 Aug 8. doi: 10.1038/s41591-025-03868.
   PubMed     Abstract available
   
   
   
5. LIANG Z, Liu S, Guo W, Deng Z, et al
   Recombinant monoclonal antibody siltartoxatug versus plasma-derived human tetanus immunoglobulin for tetanus: a randomized, double-blind, active-controlled, phase 3 trial.
   Nat Med. 2025;31:2673-2681.
   PubMed     Abstract available
   
   
   July 2025
6. ZHOU H, Jia C, Shen P, Huang C, et al
   Genomic census of invasive nontyphoidal Salmonella infections reveals global and local human-to-human transmission.
   Nat Med. 2025;31:2325-2334.
   PubMed     Abstract available
   
   
   June 2025
7. DARTOIS VA, Mizrahi V, Savic RM, Silverman JA, et al
   Strategies for shortening tuberculosis therapy.
   Nat Med. 2025;31:1765-1775.
   PubMed     Abstract available
   
   
   May 2025
8. CHAN BK, Stanley GL, Kortright KE, Vill AC, et al
   Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis.
   Nat Med. 2025;31:1494-1501.
   PubMed     Abstract available
   
   
   April 2025
9. GILBERT JA, Azad MB, Backhed F, Blaser MJ, et al
   Clinical translation of microbiome research.
   Nat Med. 2025;31:1099-1113.
   PubMed     Abstract available
   
   
   January 2025
10. JESUS GS, Gestal PFPS, Silva AF, Cavalcanti DM, et al
    Effects of conditional cash transfers on tuberculosis incidence and mortality according to race, ethnicity and socioeconomic factors in the 100 Million Brazilian Cohort.
    Nat Med. 2025 Jan 3. doi: 10.1038/s41591-024-03381.
    PubMed     Abstract available
    
    
    
11. MENON R, Bhattarai SK, Crossette E, Prince AL, et al
    Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infection.
    Nat Med. 2025;31:223-234.
    PubMed     Abstract available
    
    
    November 2024
12. PAN KF, Li WQ, Zhang L, Liu WD, et al
    Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial.
    Nat Med. 2024;30:3250-3260.
    PubMed     Abstract available
    
    
    August 2024
13. ZHAI B, Liao C, Jaggavarapu S, Tang Y, et al
    Antifungal heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infections.
    Nat Med. 2024 Aug 2. doi: 10.1038/s41591-024-03183.
    PubMed     Abstract available
    
    
    June 2024
14. CLIFF M, Welaga P, Mohammed N, Ansah P, et al
    Strategies for controlling pneumococcal disease and outbreaks during humanitarian emergencies.
    Nat Med. 2024;30:1515-1516.
    PubMed    
    
    
    May 2024
15. MENTZER AJ, Dilthey AT, Pollard M, Gurdasani D, et al
    High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response.
    Nat Med. 2024 May 13. doi: 10.1038/s41591-024-02944.
    PubMed     Abstract available
    
    
    April 2024
16. 
    Systematic testing in cholera surveillance enhances vaccine impact and cost-effectiveness.
    Nat Med. 2024 Apr 3. doi: 10.1038/s41591-024-02907.
    PubMed    
    
    
    March 2024
17. NUERMBERGER EL, Chaisson RE
    Restocking the tuberculosis drug arsenal.
    Nat Med. 2024 Mar 8. doi: 10.1038/s41591-024-02840.
    PubMed    
    
    
    
18. XU H, Zou K, Dent J, Wiens KE, et al
    Enhanced cholera surveillance to improve vaccination campaign efficiency.
    Nat Med. 2024 Mar 5. doi: 10.1038/s41591-024-02852.
    PubMed     Abstract available
    
    
    
19. HEGDE ST, Khan AI, Perez-Saez J, Khan II, et al
    Clinical surveillance systems obscure the true cholera infection burden in an endemic region.
    Nat Med. 2024;30:888-895.
    PubMed     Abstract available
    
    
    
20. KHAN S, Guo X, Awan UA
    Pakistan is failing in maternal and neonatal tetanus elimination.
    Nat Med. 2024;30:615.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.